6 results match your criteria: "University Paris Diderot and INSERM UMR-S 942[Affiliation]"
A Time-Dependent Propensity Score Matching Approach to Assess Epinephrine Use on Patients Survival Within Out-of-Hospital Cardiac Arrest Care.
J Emerg Med
October 2020
RESCUe-RESUVal Networks, Lucien Hussel Hospital, Vienne, France; Health Services and Performance Research, Claude Bernard University, Lyon, France; Emergency Department and Clinical Research Unit, Médipôle Hospital, Villeurbanne, France.
Background: Epinephrine effectiveness and safety are still questioned. It is well known that the effect of epinephrine varies depending on patients' rhythm and time to injection.
Objective: We aimed to assess the association between epinephrine use during out-of-hospital cardiac arrest (OHCA) care and patient 30-day (D30) survival.
Current treatment and unmet needs of hyperkalaemia in the emergency department.
Eur Heart J Suppl
February 2019
Baylor College of Medicine, Ben Taub General Hospital, Houston, TX, USA.
Hyperkalaemia is a common electrolyte abnormality and can cause life-threatening cardiac arrhythmia. Even though it is common in patients with diabetes, heart failure, and kidney disease, there is poor consensus over its definition and wide variability in its treatment. Medications used to treat hyperkalaemia in the emergent setting do not have robust efficacy and safety data to guide treatment leading to mismanagement due to poor choice of some agents or inappropriate dosing of others.
View Article and Find Full Text PDFCorrection to: Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients.
Intensive Care Med
November 2018
Department of Anesthesiology and Critical Care, APHP - Saint Louis Lariboisière University Hospitals, University Paris Diderot and INSERM UMR-S 942, Paris, France.
Article Synopsis
- There was a technical error in the original article that affected the code related to the Basir et al. cohort's outcomes.
- The mis-implementation led to inaccurate information being presented in the article.
- The characteristics of the cohort mentioned will be corrected and clarified in this updated version.
Improving Postdischarge Outcomes in Acute Heart Failure.
Am J Ther
March 2019
Department of Anesthesiology and Critical Care, APHP-Saint Louis Lariboisière University Hospitals, University Paris Diderot and INSERM UMR-S 942, Paris, France.
Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients.
Intensive Care Med
June 2018
Department of Anesthesiology and Critical Care, APHP - Saint Louis Lariboisière University Hospitals, University Paris Diderot and INSERM UMR-S 942, Paris, France.
Objective: Catecholamines have been the mainstay of pharmacological treatment of cardiogenic shock (CS). Recently, use of epinephrine has been associated with detrimental outcomes. In the present study we aimed to evaluate the association between epinephrine use and short-term mortality in all-cause CS patients.
View Article and Find Full Text PDFHeart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study.
Eur J Heart Fail
February 2018
Department of Anesthesiology and Critical Care, APHP - Saint Louis Lariboisière University Hospitals, University Paris Diderot and INSERM UMR-S 942, Paris, France.
Aims: Heart failure oral therapies (HFOTs), including beta-blockers (BB), renin-angiotensin system inhibitors (RASi) and mineralocorticoid receptor antagonists, administered before hospital discharge after acute heart failure (AHF) might improve outcome. However, concerns have been raised because early administration of HFOTs may worsen patient's condition. We hypothesized that HFOTs at hospital discharge might be associated with better post-discharge survival.
View Article and Find Full Text PDF